Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00873691 · ClinicalTrials.gov registry record

Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants

A clinical trial, sponsored by Abbott Medical Devices.

Completed
Registry status
129
Enrollment target

NCT00873691: Completed study, sponsored by Abbott Medical Devices.

NCT00873691 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00873691 has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
129 participants
Enrollment target

Study Summary

The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform in patients with right-sided implants.

Interventions

  • DEVICE ICD

Trial Details

FieldValue
Enrollment Target 129 participants
Start Date 2009-03
Est. Completion 2011-11
Abbott Medical Devices

261 total trials

What the finished NCT00873691 record still lists

NCT00873691 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which ICD is the first listed.

NCT00873691 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00873691 about?

NCT00873691 is a clinical study titled "Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants". The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform in patients with right-sided implants.

What is the current status of trial NCT00873691?

This trial is currently completed. The enrollment target is 129 participants. The study started on 2009-03. Estimated completion is 2011-11.

What interventions are being tested in trial NCT00873691?

The interventions under investigation include: ICD (DEVICE).

Who is sponsoring clinical trial NCT00873691?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03619850 · 129 participants · Phase 3

    A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

  • NCT05704361 · 129 participants · Phase 1

    A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis

  • NCT05919849 · 129 participants · Phase 1

    Supporting Parents in Affirming Their Children's Experiences of Stigma

  • NCT06313749 · 129 participants · NA

    Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00873691, the US trial registry maintained by the National Library of Medicine. NCT00873691 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.